Adherence to Highly Active Antiretroviral Therapy (HAART): A Meta-Analysis

被引:247
作者
Ortego, Carmen [1 ]
Huedo-Medina, Tania B. [2 ]
Llorca, Javier [3 ,4 ,5 ]
Sevilla, Lourdes [1 ]
Santos, Pilar [1 ]
Rodriguez, Elias [1 ]
Warren, Michelle R. [2 ]
Vejo, Javier [1 ]
机构
[1] Univ Cantabria, Dept Nursing, Santander, Spain
[2] Univ Connecticut, CHIP, Storrs, CT USA
[3] Univ Cantabria, Grp Epidemiol & Computat Biol, Cantabria, Spain
[4] CIBERESP, Barcelona, Spain
[5] IFIMAV, Santander, Spain
关键词
HAART; Acquired immunodeficiency syndrome; HIV; Adherence; Meta-analysis; Human development; HIV-INFECTED PATIENTS; DRUG-RESISTANCE MUTATIONS; SELF-REPORTED ADHERENCE; VIROLOGICAL TREATMENT RESPONSE; QUALITY-OF-LIFE; PATIENT ADHERENCE; PUBLICATION BIAS; TREATMENT SATISFACTION; MEDICATION ADHERENCE; CLINICAL PROGRESSION;
D O I
10.1007/s10461-011-9942-x
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
This meta-analysis synthesizes eighty-four observational studies, conducted across twenty countries, to determine the mean proportion of people who reported >= 90% adherence to prescribed highly active antiretroviral therapy (HAART) and to identify the factors associated with high levels of adherence. Eight electronic databases were searched to locate all relevant studies available by January 2010, which were then coded for sample characteristics and adherence levels. The average rate of reporting >= 90% adherent HAART adherence is 62%. However, this proportion varies greatly across studies. In particular, a greater proportion of individuals maintaining >= 90% adherence to HAART is more likely in studies with higher proportions of men who have sex with men (MSM) and lower proportions of injection drug users (IDU), with participants in an earlier stage of infection, and in studies conducted in countries characterized by lower Human Development Index (HDI) scores.
引用
收藏
页码:1381 / 1396
页数:16
相关论文
共 130 条
  • [1] Good adherence to HAART and improved survival in a community HIV/AIDS treatment and care programme: the experience of The AIDS Support Organization (TASO), Kampala, Uganda
    Abaasa, Andrew M.
    Todd, Jim
    Ekoru, Kenneth
    Kalyango, Joan N.
    Levin, Jonathan
    Odeke, Emmanuel
    Karamagi, Charles A. S.
    [J]. BMC HEALTH SERVICES RESEARCH, 2008, 8 (1)
  • [2] AETC. AIDS Education and Training Centers. National Resource Center, 2011, HIV CLASS CDC WHO ST
  • [3] Aiken LS., 1991, MULTIPLE REGRESSION
  • [4] Ammassari A, 2001, J ACQ IMMUN DEF SYND, V28, P445, DOI 10.1097/00042560-200112150-00006
  • [5] [Anonymous], STAT HUM DEV REP
  • [6] [Anonymous], EUR J INTERN MED
  • [7] [Anonymous], 2011, World development indicators
  • [8] The Impact of Neuropsychological Functioning on Adherence to HAART in HIV-Infected Substance Abuse Patients
    Applebaum, Allison J.
    Reilly, Laura C.
    Gonzalez, Jeffrey S.
    Richardson, Mark A.
    Leveroni, Catherine L.
    Safren, Steven A.
    [J]. AIDS PATIENT CARE AND STDS, 2009, 23 (06) : 455 - 462
  • [9] Gender and Other Psychosocial Factors as Predictors of Adherence to Highly Active Antiretroviral Therapy (HAART) in Adults with Comorbid HIV/AIDS, Psychiatric and Substance-related Disorder
    Applebaum, Allison J.
    Richardson, Mark A.
    Brady, Stephen M.
    Brief, Deborah J.
    Keane, Terence M.
    [J]. AIDS AND BEHAVIOR, 2009, 13 (01) : 60 - 65
  • [10] Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: Comparison of self-report and electronic monitoring
    Arnsten, JH
    Demas, PA
    Farzadegan, H
    Grant, RW
    Gourevitch, MN
    Chang, CJ
    Buono, D
    Eckholdt, H
    Howard, AA
    Schoenbaum, EE
    [J]. CLINICAL INFECTIOUS DISEASES, 2001, 33 (08) : 1417 - 1423